Position in AMGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$3,129,078
+$201,686 QoQ
Shares Held
8,641
+3.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,051
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DONALDSON CAPITAL MANAGEMENT, LLC holds $353,052,379 across 10 Drug Manufacturers - General names. AMGN ranks #6 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
485,608 | $122,198,397 | |
| 2 | LLY |
ELI LILLY & Co
|
88,678 | $106,363,062 | |
| 3 | MRK |
Merck & Co., Inc.
|
798,673 | $102,629,480 | |
| 4 | JNJ |
Johnson & Johnson
|
37,882 | $9,620,891 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
71,766 | $4,135,156 | |
| 6 | AMGN |
Amgen Inc
This page
|
8,641 | $3,129,078 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
18,498 | $2,337,037 | |
| 8 | PFE |
Pfizer Inc
|
52,832 | $1,272,194 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,129,078 | 8,641 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,927,392 | 8,320 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,761,841 | 8,438 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $2,385,154 | 8,452 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,376,914 | 8,513 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,714,223 | 8,712 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $2,446,888 | 9,388 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,059,706 | 9,496 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $3,215,422 | 10,291 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $2,925,652 | 10,290 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $3,184,637 | 11,057 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $4,226,788 | 15,727 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $3,552,986 | 16,003 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $3,962,282 | 16,390 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $4,356,934 | 16,589 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $3,805,653 | 16,884 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $4,137,073 | 17,004 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,132,461 | 17,089 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,937,199 | 17,501 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $3,778,365 | 17,768 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $4,496,212 | 18,446 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $4,838,110 | 19,445 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $4,425,040 | 19,246 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $4,977,469 | 19,584 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $4,626,865 | 19,617 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $4,057,640 | 20,015 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||